ABT · Abbott Laboratories · Metrics
$98.97
-1.98 (-1.96%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$174.90B
Shares
1.74B
Volume · Sep 30
3.35M
Avg daily vol (3M)
9.76M
ABT metrics
92 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$100.95
Market cap
$174.90B
Price action
20 metricsPrice change (1W)
-2.6%
Price change (30D)
-8.5%
Price change (3M)
+11.3%
Price change (6M)
-1.7%
Price change (YTD)
-19.4%
Price change (1Y)
-24.2%
Trailing year
Price change (5Y)
-15.5%
52-week high
$134.59
52-week low
$82.56
Change from 52-week high
-25.0%
Change from 52-week low
+22.3%
Annualized volatility
26.9%
Annualized volatility (3M)
31.1%
Beta
0.0
RSI (14D)
35.2
Price vs SMA 50
-5.7%
Price vs SMA 200
-3.3%
Avg volume (3M)
9.76M
Relative volume
0.8
Average dollar volume
$1.01B
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
1.74B
Valuation
12 metricsP / E (TTM)
28.3
Trailing earnings · reciprocal yield 3.5%
PEG ratio
—
EV / revenue
4.5×
reciprocal yield 22.4%
EV / EBITDA
—
EV / EBIT
26.2×
reciprocal yield 3.8%
P / sales
3.9×
reciprocal yield 25.8%
P / book
3.4
reciprocal yield 29.8%
FCF yield
4.2%
TTM · current market cap
Buyback yield
0.5%
P / FCF
23.7
reciprocal yield 4.2%
P / operating cash flow
18.5
reciprocal yield 5.4%
Earnings yield
3.6%
Historical valuation
8 metricsP / E historical average (3Y)
27.7×
reciprocal yield 3.6%
P / E historical average (5Y)
28.2×
reciprocal yield 3.5%
EV / revenue historical average (3Y)
4.9×
reciprocal yield 20.4%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.4%
EV / EBIT historical average (3Y)
29.8×
reciprocal yield 3.4%
EV / EBIT historical average (5Y)
28.0×
reciprocal yield 3.6%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
66.7%
Shareholder yield
2.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-16
Profitability
9 metricsGross margin
56.4%
Operating margin
17.1%
Trailing 12 months
Net margin
13.9%
Gross profit (TTM)
$16.74B
Operating profit (TTM)
$7.71B
Net income (TTM)
$6.28B
Trailing 12 months
Diluted EPS (TTM)
$3.57
FCF margin
16.3%
Effective tax rate
22.9%
Growth
11 metricsRevenue growth YoY
+7.8%
Year over year
Net income growth YoY
-18.7%
Revenue (TTM)
$45.13B
Trailing 12 months
EPS growth YoY
-19.7%
Shares change YoY
0.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.5%
Revenue CAGR (5Y)
+5.1%
EPS CAGR (3Y)
-1.6%
EPS CAGR (5Y)
+8.3%
FCF CAGR (3Y)
-1.8%
FCF CAGR (5Y)
+5.3%
Quality
14 metricsReturn on equity
12.1%
Return on assets
5.7%
Debt / equity
0.7
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
$7.38B
Quick ratio
1.0
Interest coverage
14.4
Net debt / EBITDA
—
Return on invested capital
7.5%
Trailing 12 months
Net cash
−$26.75B
Latest balance sheet
Cash & equivalents
$6.80B
Total assets
$110.43B
Total debt
$34.05B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$9.46B
Capital expenditures (TTM)
$2.09B
R&D (TTM)
$2.99B
SG&A (TTM)
$13.01B
Stock compensation (TTM)
$692.00M
R&D / revenue
6.6%
Stock compensation / revenue
1.5%
Ownership (13F)
3 metrics13F filers
2,990
13F filer change QoQ
-137
Institutional ownership
80.5%
Short interest
3 metricsShort interest
1.1%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
−$46.85M
Insider-sentiment score
18 / 100
Risk flags
1 metricsGoing concern
—